Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Pan Global Ramps Up Drilling at Escacena Copper Project, Expands Land Position in Spain
Pan Global Resources is stepping up exploration at its Escacena copper project in southern Spain with an eight-hole, 2,500-meter drill progr
BioCryst Shuts Alabama Discovery Site, Pivots to External Licensing Deals
BioCryst Pharmaceuticals is closing its Birmingham discovery site by 2026 and cutting its 2026 expense outlook. The rare-disease drugmaker p
Martin Marietta Bets $13.5 Billion on Lime Demand in Infrastructure Boom
Martin Marietta Materials is acquiring lime and limestone supplier Lhoist North America for $13.5 billion. The deal reflects a bet that US i
RBC Sees Sales Pickup at Action but Flags Margin Pressure and Slow US Rollout
RBC Capital Markets says discount retailer Action has seen better sales momentum recently, but still sees risks to 3i Group's near-term resu
Libco Insaat Buys 32% Stake in Tekfen as Oyak Pursues Separate Deal
Libco Insaat has agreed to buy a 32.08% stake in Tekfen Holding, adding to a flurry of ownership changes. The deal comes weeks after Turkey'
Comcast to Spin Off NBCUniversal and Sky, Creating Two Public Companies
Comcast will spin off NBCUniversal and Sky into a new public company, separating its media assets from its cable-and-broadband business. The
Korn Ferry Buys UK Recruiter AMS for $1.12 Billion, Shares Rise
Korn Ferry announced a $1.12 billion deal to buy UK recruiter AMS, sending its shares up over 3% in premarket trading. The acquisition is ex
RBC: Smith & Nephew Faces Tight Path to 2026 Growth Target, Q3 Key
RBC Capital Markets warns Smith & Nephew has little room for error to achieve its roughly 6% 2026 growth target. The bank says a clear secon
RBC Hikes Avolta Price Target After DFS Okinawa Deal, Sees Up to CHF100M Revenue Boost
RBC Capital Markets lifted its price target for Avolta to 57 francs after the Swiss travel retailer agreed to buy DFS's Okinawa operations f
Zymeworks to Acquire Theravance Biopharma for $929 Million in All-Cash Deal
Zymeworks will acquire Theravance Biopharma for $17 per share in a $929 million all-cash deal. The transaction includes a 10-year contingent
CVC to Buy Dessert Supplier IRCA from Advent in Latest Private Equity-to-Private Equity Deal
CVC Capital Partners has agreed to buy IRCA, an Italian supplier of dessert ingredients, from rival private equity firm Advent International
Bridgepoint Buys Kayne Anderson Real Estate for $1.4 Billion, Shares Jump 12%
Bridgepoint, a UK private equity firm, agreed to buy Kayne Anderson's US real estate business for $1.4 billion. The deal adds $22 billion in